paxlovid

  1. Mij

    Association of Treatment With Nirmatrelvir and the Risk of Post–COVID-19 Condition, 2023, Yan Xie, PhD et al

    Key Points Question Is treatment with nirmatrelvir in the acute phase of SARS-CoV-2 infection associated with a lower risk of post–COVID-19 condition (PCC)? Findings In this cohort study of 281 793 people with SARS-CoV-2 infection who had at least 1 risk factor for progression to severe...
    • Mij
    • Thread
    • antivirals nirmatrelvir paxlovid prevention viral persistence
    • Replies: 5
    • Forum: Long Covid research
  2. LarsSG

    [Preprint] Nirmatrelvir and the Risk of Post-Acute Sequelae of COVID-19, 2022, Al-Aly et al

    Abstract: Long Covid -- the disease encompassing the post-acute sequelae of SARS-CoV-2 (PASC) -- affects millions of people around the world. Prevention of PASC is an urgent public health priority. In this work, we aimed to examine whether treatment with nirmatrelvir in the acute phase of...
  3. RedFox

    Protocol RECOVER Treatment Study: Paxlovid for long Covid

    The RECOVER Initiative is doing a trial on Paxlovid for long Covid. Here's the listing on ClinicalTrials.gov: SARS CoV-2 Viral Persistence Study (PASC) - Study of Long COVID-19 (PASC) Highlights: Double-blind multi-center trial in the US 1700 participants They'll take the drug for 15 days...
Back
Top Bottom